admin_auro

April 3, 2015

Published by admin_auro at April 3, 2015

Categories

Uncategorized

Molecular therapy for Inflammation-mediated T2DM: NRF2 suppresses adipose tissue inflammation and insulin resistance via down regulation of Angptl2, 3/April/2015, 21.17

A study from the Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan shows that “Angiopoietin-like protein 2 promotes chronic adipose tissue […]

April 3, 2015

Published by admin_auro at April 3, 2015

Categories

Uncategorized

Natural product-based Regenerative therapy for DM: Withaferin A promotes an insulin sensitized state via up regulation of reprogramming protein Lin28, 3/April/2015, 21.12

A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates […]

April 3, 2015

Published by admin_auro at April 3, 2015

Categories

Uncategorized

Life-span extension therapy: EMX2 inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 3/April/2015, 18.24

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 […]

April 3, 2015

Published by admin_auro at April 3, 2015

Categories

Uncategorized

Small molecule-based therapy for p53-deficient tumors: Bicalutamide, an antrogen receptor antagonist, suppresses & increases the expression of DNp63α & IAPP(Amylin), respectively, and induces regression of p53-mutated human tumors via down regulation of its target gene, 3/April/2015, 18.19

A recent study from the Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [2] […]